KVC Blogs, OpEds, Testimonies, Articles

ARTICLES AND CHAPTERS

Goodman N. (2021). Lift Every Voice and Sing: Working for Equity for Children with Cancer. A Gluck & C Fuchs (Eds.), A New Deal for Cancer. Lessons from a 50 Year War. NY, NY. Public Affairs

Gerasimov E.(2020) Before It's Too Late: Multistakeholder Perspectives on Compassionate Access to Investigational Drugs for Pediatric Patients With Cancer. Am Soc Clin Oncol Educ Book. May;40:1-10. doi: 10.1200/EDBK_278995.

Lyerly HK. Global Development of Anticancer Therapies for Rare Cancers, Pediatric Cancers, and Molecular Subtypes of Common Cancers. Oncol. 2018 Dec;4:1-11. doi: 10.1200/JGO.18.00092.PMID: 30521412

The Childhood Cancer Data Initiative: Using the Power of Data to Learn From and Improve Outcomes for Every Child and Young Adult With Pediatric Cancer.

Flores-Toro JA, Jagu S, Armstrong GT, Arons DF, Aune GJ, Chanock SJ, Hawkins DS, Heath A, Helman LJ, Janeway KA, Levine JE, Miller E, Penberthy L, Roberts CWM, Shalley ER, Shern JF, Smith MA, Staudt LM, Volchenboum SL, Zhang J, Zenklusen JC, Lowy DR, Sharpless NE, Guidry Auvil JM, Kerlavage AR, Widemann BC, Reaman GH, Kibbe WA, Doroshow JH; Childhood Cancer Data Initiative Working Groups.J Clin Oncol. 2023 Aug 20;41(24):4045-4053. doi: 10.1200/JCO.22.02208. Epub 2023 Jun 2.PMID: 37267580

How to correct the market for children's cancer drugs.

Goodman NF.Nat Med. 2022 Apr;28(4):613. doi: 10.1038/s41591-022-01747-w.PMID: 35440718 No abstract available.

Before It's Too Late: Multistakeholder Perspectives on Compassionate Access to Investigational Drugs for Pediatric Patients With Cancer.

Gerasimov E, Donoghue M, Bilenker J, Watt T, Goodman N, Laetsch TW.Am Soc Clin Oncol Educ Book. 2020 May;40:1-10. doi: 10.1200/EDBK_278995.PMID: 32412804 Free article. Review.

Physician perspectives on compassionate use in pediatric oncology.

Moerdler S, Zhang L, Gerasimov E, Zhu C, Wolinsky T, Roth M, Goodman N, Weiser DA.Pediatr Blood Cancer. 2019 Mar;66(3):e27545. doi: 10.1002/pbc.27545. Epub 2018 Nov 8.PMID: 30408307

Anti-interleukin-12 antibody for active Crohn's disease.

Mannon PJ, Fuss IJ, Mayer L, Elson CO, Sandborn WJ, Present D, Dolin B, Goodman N, Groden C, Hornung RL, Quezado M, Yang Z, Neurath MF, Salfeld J, Veldman GM, Schwertschlag U, Strober W; Anti-IL-12 Crohn's Disease Study Group.N Engl J Med. 2004 Nov 11;351(20):2069-79. doi: 10.1056/NEJMoa033402.PMID: 15537905 . Clinical Trial.

Text Messaging to Improve Disease Management in Patients With Painful Diabetic Peripheral Neuropathy.

Bauer V, Goodman N, Lapin B, Cooley C, Wang E, Craig TL, Glosner SE, Juhn MS, Cappelleri JC, Sadosky AB, Masi C.Diabetes Educ. 2018 Jun;44(3):237-248. doi: 10.1177/0145721718767400. Epub 2018 Mar 28.PMID: 29589820 Clinical Trial.

Global Development of Anticancer Therapies for Rare Cancers, Pediatric Cancers, and Molecular Subtypes of Common Cancers.

Lyerly HK, Ren J, Canetta R, Kim GH, Nagai S, Yamaguchi T, Hatogai K, Katayama H, Da Rocha Dias S, McManus D, Soltys K, Yang Z, Olopade O, Goodman N, Reaman G, Gross T.J Glob Oncol. 2018 Dec;4:1-11. doi: 10.1200/JGO.18.00092.PMID: 30521412

A real-time PCR assay for DNA-methylation using methylation-specific blockers.

Cottrell SE, Distler J, Goodman NS, Mooney SH, Kluth A, Olek A, Schwope I, Tetzner R, Ziebarth H, Berlin K.Nucleic Acids Res. 2004 Jan 13;32(1):e10. doi: 10.1093/nar/gnh008.PMID: 14722226

Modernizing Clinical Trial Eligibility: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Minimum Age Working Group.

Gore L, Ivy SP, Balis FM, Rubin E, Thornton K, Donoghue M, Roberts S, Bruinooge S, Ersek J, Goodman N, Schenkel C, Reaman G.J Clin Oncol. 2017 Nov 20;35(33):3781-3787. doi: 10.1200/JCO.2017.74.4144. Epub 2017 Oct 2.PMID: 28968169